Skip to main content
SpringerLink
Log in

Barnidipine

  • Adis New Drug Profile
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

  • ▴ Barnidipine is an antihypertensive drag belonging to the dihydropyridine (DHP) group of calcium antagonists. It is available in a modified-release formulation which has a gradual onset of action and is effective in a single daily oral dose of 10 to 20mg.

  • ▴ Barnidipine has selective action against cardiovascular calcium antagonist receptors and its antihypertensive action is related to the reduction of peripheral vascular resistance secondary to its vasodilatory action.

  • ▴ The clinical antihypertensive efficacy of barnidipine is similar to that of other DHP calcium antagonists such as nitrendipine and amlodipine, and antihypertensives belonging to other drag classes such as atenolol and enalapril.

  • ▴ Barnidipine has been found to be as efficacious and well tolerated as hydrochlorothiazide in the management of hypertension in elderly patients.

  • ▴ Barnidipine is generally well tolerated. As with other DHP calcium antagonists, vasodilator adverse events such as headache, flushing and peripheral oedema account for most of the adverse events reported with its use and are usually transient. Oedema is less frequent than with amlodipine and nitrendipine. Its use is not associated with reflex tachycardia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ramsay LE, Williams B, Johnston GD, et al. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999 Sep 4; 319: 630–5

    Article  PubMed  CAS  Google Scholar 

  2. Alderman M, Arakawa K, Beilin L, et al. 1999 World Health Organization — International Society of Hypertension Guidelines for the Management of Hypertension. Blood Press 1999; 8 Suppl. 1: 9–43

    Google Scholar 

  3. Singh V, Christiana J, Frishman WH. How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Drugs 1999 Oct; 58: 579–87

    Article  PubMed  CAS  Google Scholar 

  4. Yamada S, Matsuoka Y, Kato Y, et al. A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats. J Pharmacol Exp Ther 1992 Aug; 262: 589–94

    PubMed  CAS  Google Scholar 

  5. Yamada S, Matsuoka Y, Kimura R. Correlation between the plasma concentration of mepirodipine and its occupancy of Ca2+ antagonist receptors in rats. Pharm Res 1993 Sep; 10: 1346–9

    Article  PubMed  CAS  Google Scholar 

  6. Inagaki O, Asano M, Takenaka T. In vitro and in vivo vasodilatory activity of barnidipine and its enantiomers. Biol Pharm Bull 1999 Feb; 22: 151–6

    Article  PubMed  CAS  Google Scholar 

  7. van-der-Lee R, Kam KL, Pfaffendorf M, et al. Differential time course of the vasodilator action of various calcium antagonists. Fundam Clin Pharmacol 1998; 12: 607–12

    Article  PubMed  CAS  Google Scholar 

  8. VasextenTM monograph. Yamanouchi Europe B.V

  9. Noda H, Fujita T, Ogata E. The role of renal hemodynamics in the antihypertensive action of mepirodipine, a new calcium antagonist. Jpn Circ J 1992 Jan; 56: 21–6

    Article  PubMed  CAS  Google Scholar 

  10. Argenziano L, Izzo R, Iovino G, et al. Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients. Blood Press Suppl 1998; 1: 9–14

    PubMed  CAS  Google Scholar 

  11. Ohya Y, Abe I, Ohta Y, et al. Natriuretic effect of barnidipine, a long-acting dihydropyridine calcium channel blocker, in patients with essential hypertension. Int J Clin Pharmacol Ther 2000 Jun; 38: 304–8

    PubMed  CAS  Google Scholar 

  12. Motomura S, Hashimoto K. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine. Jpn J Pharmacol 1990 Feb; 52: 319–30

    Article  PubMed  CAS  Google Scholar 

  13. Kimura K, Suzuki N, Mise N, et al. Effects of barnidipine hydrochloride, a calcium channel blocker, on renal microcirculation in rats: A pilot study. Curr Ther Res Clin Exp 1998; 59(12): 826–34

    Article  CAS  Google Scholar 

  14. Hashimoto M, Yamauchi T, Ogura T, et al. Treatment with a Ca(2+) channel blocker, barnidipine, reduces platelet-derived growth factor B-chain mRNA in glomeruli of spontaneously hypertensive rats. Am J Nephrol 1999; 19: 615–21

    Article  PubMed  CAS  Google Scholar 

  15. Kosegawa I, Inaba M, Morita T, et al. Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension. Clin Exp Hypertens 1998 Oct; 20: 751–61

    Article  PubMed  CAS  Google Scholar 

  16. Sakai T, Teramura T, Okamiya H, et al. A review on barnidipine: a novel calcium antagonist. Cardiovasc Drug Rev 1997; 15(4): 273–90

    Article  CAS  Google Scholar 

  17. Teramura T, Watanabe T, Higuchi S, et al. Metabolism and pharmacokinetics of barnidipine hydrochloride, a calcium channel blocker, in man following oral administration of its sustained release formulation. Xenobiotica 1997 Feb; 27: 203–16

    Article  PubMed  CAS  Google Scholar 

  18. Teramura T, Tokunaga T, Matsumoto H, et al. Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog. Xenobiotica 1996 Feb; 26: 177–87

    Article  PubMed  CAS  Google Scholar 

  19. Teramura T, Fukunaga Y, Van-Hoogdalem EJ, et al. Examination of metabolic pathways and identification of human liver cytochrome P450 isozymes responsible for the metabolism of barnidipine, a calcium channel blocker. Xenobiotica 1997 Sep; 27: 885–900

    Article  PubMed  CAS  Google Scholar 

  20. Hart W, Holwerda NJ. Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Dutch Barnidipine Multicenter Study Group. Cardiovasc Drugs Ther 1997 Nov; 11: 637–43

    Article  PubMed  CAS  Google Scholar 

  21. Smilde JG. The long-term efficacy and safety profile of barnidipine. Int J Clin Pract 2000 Nov; 114 Suppl.: 20–6

    CAS  Google Scholar 

  22. Imai Y, Abe K, Nishiyama A, et al. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24h, daytime, and nighttime. Barnidipine Study Group. Am J Hypertens 1997 Dec; 10 (12 Pt 1): 1415–9

    Google Scholar 

  23. Smilde JG, Holwerda NJ, Lustermans FAT. Impact of barnidipine on 24-hour ambulatory blood pressure in patients with mild to moderate esential hypertension. J Hypertens 2000 Jun; 18 Suppl. 2: 56

    Google Scholar 

  24. Huh WS, Kim YS, Han JS, et al. Antihypertensive efficacy and tolerability of barnidipine hydrochloride in patients with renal parenchymal hypertension. Curr Ther Res Clin Exp 2000 Jul; 61: 395–405

    Article  CAS  Google Scholar 

  25. Spieker C. Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension. Blood Press Suppl 1998; 1: 15–21

    Article  PubMed  CAS  Google Scholar 

  26. Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press Suppl 1998; 1: 22–6

    PubMed  CAS  Google Scholar 

  27. Otterstad JE, Ruilope LM. Treatment of hypertension in the very old. Int J Clin Pract 2000 Nov; 114 Suppl.: 10–9

    Google Scholar 

  28. Naber FB, Hage R, Mortelmans J. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study. Int J Clin Pract 2000 Nov; 114 Suppl.: 27–35

    CAS  Google Scholar 

  29. van-der-Velden JW, Beudeker HJ, Nishi M. Diversity and intensity of adverse events in the treatment of hypertension with barnidipine. Blood Press Suppl 1998; 1: 27–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adis International Limited, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, Auckland 10, New Zealand

    Harinder S. Malhotra & Greg L. Plosker

Authors
  1. Harinder S. Malhotra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Greg L. Plosker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harinder S. Malhotra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malhotra, H.S., Plosker, G.L. Barnidipine. Drugs 61, 989–996 (2001). https://doi.org/10.2165/00003495-200161070-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200161070-00007

Keywords

Search

Navigation